Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_23878 | 39 | 0.81 | Mlig455_049589 | Neo: - Age: Up-Down-Up |
CHRNA10 | Mlig455_049589 {REF} {Length: 3291} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=185.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=98.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=247, Expect=6e-75]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=246, Expect=7e-74]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=246, Expect=7e-74]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=2e-73]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=238, Expect=3e-71]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=249, Expect=2e-75]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=245, Expect=3e-74]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=243, Expect=1e-73]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=252, Expect=5e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=253, Expect=2e-77]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=243, Expect=4e-73]} {RNA1310_41255} {RNA815_44396} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.541 | 1.139 | 0.99982 | 1.00000 | |
RegionR2 | 1.317 | 1.139 | 0.57510 | 0.93274 | |
RegionR3 | 1.311 | 1.139 | 0.52429 | 1.00000 | |
RegionR4 | 1.531 | 1.139 | 0.53374 | 0.85706 | |
RegionR5 | -0.311 | 1.139 | 0.81716 | 1.00000 | |
RegionR6 | 1.995 | 1.139 | 0.33038 | 0.91859 | |
RegionR7 | -2.257 | 1.139 | 0.99981 | 1.00000 | |
RegionR8 | -2.047 | 1.139 | 0.99983 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.622 | 1.139 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.014 | 1.139 | 0.99926 | 1.00000 | |
RegenerationR3 | 0.782 | 1.139 | 0.78997 | 0.97879 | |
RegenerationR4 | -0.432 | 1.139 | 0.87528 | 1.00000 | |
RegenerationR5 | 1.321 | 1.139 | 0.62285 | 0.91988 | |
RegenerationR6 | 0.445 | 1.139 | 0.89169 | 1.00000 | |
RegenerationBL | -1.621 | 1.139 | 1.00000 | 1.00000 | |
RegenerationTP | 3.145 | 1.139 | 0.36186 | 0.80178 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_23878 | 39 | 0.81 | Mlig455_049589 | Neo: - Age: Up-Down-Up |
CHRNA10 | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_049589 {REF} {Length: 3291} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=185.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=98.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=247, Expect=6e-75]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=246, Expect=7e-74]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=246, Expect=7e-74]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=2e-73]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=238, Expect=3e-71]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=249, Expect=2e-75]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=245, Expect=3e-74]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=243, Expect=1e-73]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=252, Expect=5e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=253, Expect=2e-77]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=243, Expect=4e-73]} {RNA1310_41255} {RNA815_44396} |
2. | MligTC455_35859 | 13 | 0.28 | Mlig455_031846 | Neo: - Age: - |
0.986 | - | - | 0.986 | - | - | - | Mlig455_031846 {REF} {Length: 4777} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=63.2]} {Mouse: ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=58.2, Expect=8e-08]} {RNA1310_60289} {RNA815_27966} | |
3. | MligTC455_41541 | 30 | 0.62 | Mlig455_064895 | Neo: - Age: - |
GLUL | 0.983 | - | - | 0.983 | - | - | - | Mlig455_064895 {REF} {Length: 1633} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.2]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=45.1]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=503, Expect=4e-177]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=503, Expect=2e-179]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=510, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=511, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=546, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.1, RNA1509_47000} {RNA1509_47000, RNA815_4116.6} |
4. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 0.973 | - | - | 0.973 | - | - | - | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
5. | MligTC455_49007 | 27 | 0.57 | Mlig455_041690 | Neo: - Age: - |
0.97 | - | - | 0.970 | - | - | - | Mlig455_041690 {REF} {Length: 803} {NoTransDecoderORF} {RNA1509_46943} {RNA1310_69788} {RNA815_38067} | |
6. | MligTC455_14102 | 31 | 0.65 | Mlig455_006004 | Neo: - Age: - |
0.969 | - | - | 0.969 | - | - | - | Mlig455_006004 {REF} {Length: 1106} {RNA1310_32319} {RNA815_18072} | |
7. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 0.963 | - | - | 0.963 | - | - | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
8. | MligTC455_10134 | 17 | 0.36 | Mlig455_038704 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_038704 {REF} {Length: 689} {NoTransDecoderORF} | |
9. | MligTC455_30003 | 90 | 1.88 | Mlig455_001968 | Neo: - Age: - |
ITGB6 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_001968 {REF} {Length: 4889} {TRANSSPLICED} {Pfam: Integrin beta chain VWA domain [PF00362.20, score=245.0]; Integrin beta cytoplasmic domain [PF08725.13, score=58.3]; Integrin plexin domain [PF17205.5, score=42.3]; EGF-like domain [PF07974.15, score=33.8]} {Human: ENSG00000115221, ITGB6, integrin subunit beta 6, [RH, Score=368, Expect=8e-115]; ENSG00000082781, ITGB5, integrin subunit beta 5, [RH, Score=362, Expect=2e-112]; ENSG00000139626, ITGB7, integrin subunit beta 7, [RH, Score=362, Expect=3e-112]; ENSG00000150093, ITGB1, integrin subunit beta 1, [RH, Score=353, Expect=8e-109]} {Mouse: ENSMUSG00000022817, Itgb5, integrin beta 5, [RH, Score=370, Expect=2e-115]; ENSMUSG00000026971, Itgb6, integrin beta 6, [RH, Score=366, Expect=3e-114]; ENSMUSG00000020689, Itgb3, integrin beta 3, [RH, Score=357, Expect=1e-110]; ENSMUSG00000025809, Itgb1, integrin beta 1 (fibronectin receptor beta), [RH, Score=353, Expect=3e-109]; ENSMUSG00000001281, Itgb7, integrin beta 7, [RH, Score=353, Expect=3e-109]} {Dmel: FBgn0004657, mys, myospheroid, [RH, Score=368, Expect=2e-114]} {Celegans: WBGene00003930, pat-3, Integrin beta pat-3, [RH, Score=382, Expect=3e-120]} {Smed: dd_Smed_v6_2017_0_1, dd_Smed_v6_2017_0_1, [RH, Score=472, Expect=2e-154]} {RNA1509_45236, RNA1509_5228} {RNA1310_7982.1, RNA1509_45236, RNA1509_5228} {RNA1509_45236, RNA1509_5228, RNA815_793.1} |